November 13, 2026 at 11:06 AM UTC
REVIVA PHARMACEUTICALS HOLDINGS, INC. reports financial results in SEC 8-K
REVIVA PHARMACEUTICALS HOLDINGS, INC. filed an 8-K covering results of operations or financial condition and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: November 13, 2026 at 01:30 AM UTC
Open official source